Skip to main content
Top
Published in: Journal of Neurology 1/2012

Open Access 01-01-2012 | Original Communication

Diurnal and nocturnal drooling in Parkinson’s disease

Authors: J. G. Kalf, B. R. Bloem, M. Munneke

Published in: Journal of Neurology | Issue 1/2012

Login to get access

Abstract

Drooling as symptom of Parkinson’s disease (PD) has thus far been poorly defined. This uncertainty is reflected by high variations in published prevalence rates. The aim of this study was to investigate the prevalence of saliva loss versus accumulation of saliva as a possible preliminary stage, and diurnal drooling versus nocturnal drooling. In addition, we evaluated the association between drooling severity and the severity of facial and oral motor disorders. We collected age, disease duration, UPDRS III and Hoehn & Yahr stage from 104 consecutive outpatients with PD. Diurnal and nocturnal drooling was evaluated with a validated questionnaire (ROMP-saliva). A speech pathologist, blinded for drooling severity, rated facial expression, involuntary mouth opening and difficulty with nose breathing and also interviewed patients about sleeping position and nose-breathing during the night. Thirty patients (29%) had no complaints with saliva control (‘non-droolers’), 45 patients (43%) experienced accumulation of saliva or only nocturnal drooling (‘pre-droolers’), and 29 (28%) had diurnal drooling (24 of which also drooled during the night; ‘droolers’). The droolers had longer disease duration (10 vs. 7 years, p = 0.01) and drooling was independently associated with involuntary mouth opening (OR = 2.0; 95% CI 1.02–3.99) and swallowing complaints (OR = 1.2; 95% CI 1.03–1.31). Diurnal drooling—defined as dribbling of saliva while awake—is present in about 28% of PD patients. This is less than usually reported. Diurnal drooling typically appeared later in the disease course. The association with oral motor behavior should encourage the development of behavioral treatment approaches.
Literature
1.
go back to reference Arbouw ME, Movig KL, Koopmann M, Poels PJ, Guchelaar HJ, Egberts TC, Neef C, van Vugt JP (2010) Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial. Neurology 74:1203–1207PubMedCrossRef Arbouw ME, Movig KL, Koopmann M, Poels PJ, Guchelaar HJ, Egberts TC, Neef C, van Vugt JP (2010) Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial. Neurology 74:1203–1207PubMedCrossRef
2.
go back to reference Bloem BR, Kalf JG, van de Kerkhof PC, Zwarts MJ (2009) Debilitating consequences of drooling. J Neurol 256:1382–1383PubMedCrossRef Bloem BR, Kalf JG, van de Kerkhof PC, Zwarts MJ (2009) Debilitating consequences of drooling. J Neurol 256:1382–1383PubMedCrossRef
3.
go back to reference de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM (2004) Incidence of Parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 63:1240–1244PubMed de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM (2004) Incidence of Parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 63:1240–1244PubMed
4.
go back to reference Del Tredici K, Hawkes CH, Ghebremedhin E, Braak H (2010) Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease. Acta Neuropathol 119:703–713PubMedCrossRef Del Tredici K, Hawkes CH, Ghebremedhin E, Braak H (2010) Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease. Acta Neuropathol 119:703–713PubMedCrossRef
5.
go back to reference Dogu O, Apaydin D, Sevim S, Talas DU, Aral M (2004) Ultrasound-guided versus ‘blind’ intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson’s disease. Clin Neurol Neurosurg 106:93–96PubMedCrossRef Dogu O, Apaydin D, Sevim S, Talas DU, Aral M (2004) Ultrasound-guided versus ‘blind’ intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson’s disease. Clin Neurol Neurosurg 106:93–96PubMedCrossRef
6.
go back to reference Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170PubMedCrossRef Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170PubMedCrossRef
7.
go back to reference Jankovic J (2008) Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368–376PubMedCrossRef Jankovic J (2008) Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368–376PubMedCrossRef
8.
go back to reference Kalf JG, Borm GF, Swart de BJM, Bloem BR, Zwarts MJ, Munneke M (2011) Reproducibility and validity of patients-rated assessment of speech, swallowing and saliva control in Parkinson’s disease. Archives of Physical Medicine and Rehabilitation (in press) Kalf JG, Borm GF, Swart de BJM, Bloem BR, Zwarts MJ, Munneke M (2011) Reproducibility and validity of patients-rated assessment of speech, swallowing and saliva control in Parkinson’s disease. Archives of Physical Medicine and Rehabilitation (in press)
9.
go back to reference Kalf JG, de Swart BJM, Borm GF, Bloem BR, Munneke M (2009) Prevalence and definition of drooling in Parkinson’s disease: a systematic review. J Neurol 256:1391–1396PubMedCrossRef Kalf JG, de Swart BJM, Borm GF, Bloem BR, Munneke M (2009) Prevalence and definition of drooling in Parkinson’s disease: a systematic review. J Neurol 256:1391–1396PubMedCrossRef
10.
go back to reference Kalf JG, Munneke M, Engel-van den Hoek L, de Swart BJ, Borm GF, Bloem BR, Zwarts MJ (2011) Pathophysiology of diurnal drooling in Parkinson’s disease. Movement Disorders Apr 11 [Epub ahead of print] Kalf JG, Munneke M, Engel-van den Hoek L, de Swart BJ, Borm GF, Bloem BR, Zwarts MJ (2011) Pathophysiology of diurnal drooling in Parkinson’s disease. Movement Disorders Apr 11 [Epub ahead of print]
11.
go back to reference Kalf JG, Smit AM, Bloem BR, Zwarts MJ, Munneke M (2007) Impact of drooling in Parkinson’s disease. J Neurol 254:1227–1232PubMedCrossRef Kalf JG, Smit AM, Bloem BR, Zwarts MJ, Munneke M (2007) Impact of drooling in Parkinson’s disease. J Neurol 254:1227–1232PubMedCrossRef
12.
go back to reference Kusbeci OY, Koken T, Demirbas H, Koca B (2009) Sialorrhea and salivary composition in patients with Parkinson’s disease. J Neurol Sci [Turkish] 26:264–270 Kusbeci OY, Koken T, Demirbas H, Koca B (2009) Sialorrhea and salivary composition in patients with Parkinson’s disease. J Neurol Sci [Turkish] 26:264–270
13.
go back to reference Leibner J, Ramjit A, Sedig L, Dai Y, Wu SS, Jacobson C, Okun MS, Rodriguez RL, Malaty IA, Fernandez HH (2010) The impact of and the factors associated with drooling in Parkinson’s disease. Parkinsonism Relat Disord 16:475–477PubMedCrossRef Leibner J, Ramjit A, Sedig L, Dai Y, Wu SS, Jacobson C, Okun MS, Rodriguez RL, Malaty IA, Fernandez HH (2010) The impact of and the factors associated with drooling in Parkinson’s disease. Parkinsonism Relat Disord 16:475–477PubMedCrossRef
14.
go back to reference Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, Macphee G, Brown RG, Naidu Y, Clayton L, Abe K, Tsuboi Y, Macmahon D, Barone P, Rabey M, Bonuccelli U, Forbes A, Breen K, Tluk S, Olanow CW, Thomas S, Rye D, Hand A, Williams AJ, Ondo W, Chaudhuri KR (2007) Prevalence of nonmotor symptoms in Parkinsons disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 22:1623–1629PubMedCrossRef Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, Macphee G, Brown RG, Naidu Y, Clayton L, Abe K, Tsuboi Y, Macmahon D, Barone P, Rabey M, Bonuccelli U, Forbes A, Breen K, Tluk S, Olanow CW, Thomas S, Rye D, Hand A, Williams AJ, Ondo W, Chaudhuri KR (2007) Prevalence of nonmotor symptoms in Parkinsons disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 22:1623–1629PubMedCrossRef
15.
go back to reference Nobrega AC, Rodrigues B, Torres AC, Scarpel RD, Neves CA, Melo A (2008) Is drooling secondary to a swallowing disorder in patients with Parkinson’s disease? Parkinsonism Relat Disord 14:243–245PubMedCrossRef Nobrega AC, Rodrigues B, Torres AC, Scarpel RD, Neves CA, Melo A (2008) Is drooling secondary to a swallowing disorder in patients with Parkinson’s disease? Parkinsonism Relat Disord 14:243–245PubMedCrossRef
16.
go back to reference Postma AG, Heesters M, van LT (2007) Radiotherapy to the salivary glands as treatment of sialorrhea in patients with Parkinsonism. Mov Disord 22:2430–2435PubMedCrossRef Postma AG, Heesters M, van LT (2007) Radiotherapy to the salivary glands as treatment of sialorrhea in patients with Parkinsonism. Mov Disord 22:2430–2435PubMedCrossRef
18.
go back to reference Sato K, Nakashima T (2006) Human adult deglutition during sleep. Ann Otol Rhinol Laryngol 115:334–339PubMed Sato K, Nakashima T (2006) Human adult deglutition during sleep. Ann Otol Rhinol Laryngol 115:334–339PubMed
19.
go back to reference Tsuboi Y, Umemoto T, Kikuta T, Yamada T (2009) Tongue bradykinesia is related to severity of drooling in Parkinson’s disease. Parkinsonism Relat Disord 15:S71–S72CrossRef Tsuboi Y, Umemoto T, Kikuta T, Yamada T (2009) Tongue bradykinesia is related to severity of drooling in Parkinson’s disease. Parkinsonism Relat Disord 15:S71–S72CrossRef
20.
go back to reference Tumilasci OR, Cersosimo MG, Belforte JE, Micheli FE, Benarroch EE, Pazo JH (2006) Quantitative study of salivary secretion in Parkinson’s disease. Mov Disord 21:660–667PubMedCrossRef Tumilasci OR, Cersosimo MG, Belforte JE, Micheli FE, Benarroch EE, Pazo JH (2006) Quantitative study of salivary secretion in Parkinson’s disease. Mov Disord 21:660–667PubMedCrossRef
21.
go back to reference Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, van Hilten JJ (2007) Patient-reported autonomic symptoms in Parkinson disease. Neurology 69:333–341PubMedCrossRef Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, van Hilten JJ (2007) Patient-reported autonomic symptoms in Parkinson disease. Neurology 69:333–341PubMedCrossRef
Metadata
Title
Diurnal and nocturnal drooling in Parkinson’s disease
Authors
J. G. Kalf
B. R. Bloem
M. Munneke
Publication date
01-01-2012
Publisher
Springer-Verlag
Published in
Journal of Neurology / Issue 1/2012
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-011-6138-2

Other articles of this Issue 1/2012

Journal of Neurology 1/2012 Go to the issue